Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Treace Medical Concepts Inc 100 Palmetto Park Place PONTE VEDRA FL 32081 USA

www.treace.com Employees: 477 P: 904-373-5940

Sector:

Medical

Description:

Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.

Key Statistics

Overview:

Market Capitalization, $K 168,216
Enterprise Value, $K 210,176
Shares Outstanding, K 63,718
Float, K 46,055
% Float 72.28%
Short Interest, K 3,173
Short Float 4.98%
Days to Cover 3.11
Short Volume Ratio 0.37
% of Insider Shareholders 27.72%
% of Institutional Shareholders 84.08%

Financials:

Annual Sales, $ 209,360 K
Annual Net Income, $ -55,740 K
Last Quarter Sales, $ 50,210 K
Last Quarter Net Income, $ -16,290 K
EBIT, $ -48,430 K
EBITDA, $ -40,860 K

Growth:

1-Year Return -70.15%
3-Year Return -89.76%
5-Year Return 0.00%
5-Year Revenue Growth 431.10%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -0.80
EPS Growth vs. Prev Qtr 7.14%
EPS Growth vs. Prev Year -4.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TMCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.49%
Return-on-Assets % -24.27%
Profit Margin % -26.62%
Debt/Equity 0.60
Price/Sales 0.75
Price/Cash Flow N/A
Price/Book 1.87
Book Value/Share 1.41
Interest Coverage -9.60
60-Month Beta 0.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar